CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NanoenTek Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NanoenTek Inc
12F, ACE Hiend Tower 1-Cha
235-2, Guro 3-Dong, Guro-Gu
Phone: +82 262207728p:+82 262207728 SEOUL, 08389  South Korea Ticker: 039860039860

Business Summary
NanoenTek,Inc. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. It also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Chan YilJung 47 3/24/2017 8/17/2006
Managing Director Han SangCho 45 1/1/2012 8/17/2006
Assistant Managing Director Hui DonAhn 45 1/1/2011 3/19/2010
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 107 (As of 12/31/2015)
Outstanding Shares: 26,807,627 (As of 12/31/2023)
Shareholders: 22,018
Stock Exchange: KDQ
Fax Number: +82 262207721


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 17, 2024